NO150758C - Analogifremgangsmaate for fremstilling av terapeutisk virksomme bis-pyridiniumalkan- og -xylenforbindelser - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk virksomme bis-pyridiniumalkan- og -xylenforbindelser

Info

Publication number
NO150758C
NO150758C NO823274A NO823274A NO150758C NO 150758 C NO150758 C NO 150758C NO 823274 A NO823274 A NO 823274A NO 823274 A NO823274 A NO 823274A NO 150758 C NO150758 C NO 150758C
Authority
NO
Norway
Prior art keywords
alkan
pyridinium
preparation
therapeutically effective
analogy procedure
Prior art date
Application number
NO823274A
Other languages
English (en)
Other versions
NO823274L (no
NO150758B (no
Inventor
Denis Mahlon Bailey
Original Assignee
Sterling Drug Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/734,729 external-priority patent/US4107313A/en
Publication of NO823274L publication Critical patent/NO823274L/no
Application filed by Sterling Drug Inc filed Critical Sterling Drug Inc
Publication of NO150758B publication Critical patent/NO150758B/no
Publication of NO150758C publication Critical patent/NO150758C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/73Unsubstituted amino or imino radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/74Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/75Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Cosmetics (AREA)
NO823274A 1976-02-25 1982-09-28 Analogifremgangsmaate for fremstilling av terapeutisk virksomme bis-pyridiniumalkan- og -xylenforbindelser NO150758C (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US66112876A 1976-02-25 1976-02-25
US66110176A 1976-02-25 1976-02-25
US72131576A 1976-09-07 1976-09-07
US05/734,729 US4107313A (en) 1976-02-25 1976-10-22 α,α-Bis-[4-(R-amino)-1-pyridinium]xylenes and antibacterial and antifungal uses

Publications (3)

Publication Number Publication Date
NO823274L NO823274L (no) 1977-08-26
NO150758B NO150758B (no) 1984-09-03
NO150758C true NO150758C (no) 1984-12-12

Family

ID=27505307

Family Applications (2)

Application Number Title Priority Date Filing Date
NO770631A NO148779C (no) 1976-02-25 1977-02-24 Bis-pyridiniumalkaner egnet for bruk som desinfeksjonsmidler og for bekjempelse av tannplaque
NO823274A NO150758C (no) 1976-02-25 1982-09-28 Analogifremgangsmaate for fremstilling av terapeutisk virksomme bis-pyridiniumalkan- og -xylenforbindelser

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO770631A NO148779C (no) 1976-02-25 1977-02-24 Bis-pyridiniumalkaner egnet for bruk som desinfeksjonsmidler og for bekjempelse av tannplaque

Country Status (23)

Country Link
JP (1) JPS6033108B2 (no)
AR (2) AR214876A1 (no)
AT (1) AT355571B (no)
AU (1) AU510149B2 (no)
BE (1) BE851807A (no)
CA (1) CA1073911A (no)
CH (1) CH620907A5 (no)
DE (1) DE2708331A1 (no)
DK (1) DK147638C (no)
ES (1) ES456252A1 (no)
FI (1) FI66850C (no)
FR (1) FR2342286A1 (no)
GB (1) GB1533952A (no)
HK (1) HK67484A (no)
IE (1) IE45336B1 (no)
IL (1) IL51520A (no)
LU (1) LU76837A1 (no)
MX (1) MX5132E (no)
NL (1) NL186086C (no)
NO (2) NO148779C (no)
PH (2) PH22315A (no)
PT (1) PT66224B (no)
SE (1) SE432421B (no)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4420484A (en) 1979-08-13 1983-12-13 Sterling Drug Inc. Basic amino or ammonium antimicrobial agent-polyethylene glycol ester surfactant-betaine and/or amine oxide surfactant compositions and method of use therof
USRE32300E (en) * 1979-08-13 1986-12-02 Sterling Drug Inc. Basic amino or ammonium antimicrobial agent-polyethylene glycol ester surfactant-betaine and/or amine oxide surfactant compositions and method of use thereof
DE19647402A1 (de) * 1996-11-15 1998-05-20 Hoechst Schering Agrevo Gmbh Substituierte Stickstoff-Heterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Schädlingsbekämpfungsmittel
DE19647317A1 (de) * 1996-11-15 1998-05-20 Hoechst Schering Agrevo Gmbh Substituierte Stickstoff-Heterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Schädlingsbekämpfungsmittel
DE19647413A1 (de) * 1996-11-15 1998-05-20 Hoechst Schering Agrevo Gmbh Substituierte Stickstoff-Heterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Schädlingsbekämpfungsmittel
DE10005853C1 (de) * 2000-02-10 2002-02-07 Schuelke & Mayr Gmbh Verfahren zur Herstellung von Bis-(4-amino-1-pyridinium)-alkanen
DE10205883A1 (de) * 2002-02-13 2003-08-21 Schuelke & Mayr Gmbh Wässriges Antiseptikum auf Basis von Bispyridiniumalkanen
TWI278315B (en) * 2003-06-13 2007-04-11 Ind Tech Res Inst A compound having anti-virus activity
ES2237332B1 (es) * 2004-01-14 2006-11-01 Consejo Sup. Investig. Cientificas Derivados de piridinio y quinolinio.
DE102005002645A1 (de) 2005-01-19 2006-07-20 Schülke & Mayr GmbH Alkoholische Zusammensetzungen für die Desinfektion
DE102005002644A1 (de) * 2005-01-19 2006-07-20 Schülke & Mayr GmbH Zusammensetzungen für die hygienische Händedesinfektion und die desinfizierende Händewaschung
DE102005002643B4 (de) * 2005-01-19 2007-11-22 Schülke & Mayr GmbH Zusammensetzungen für die hygienische Händedesinfektion und die desinfizierende Händewaschung
DE102005045145A1 (de) * 2005-09-15 2007-03-29 Schülke & Mayr GmbH Verwendung von Octenidindihydrochlorid in halbfesten Zubereitungen
DE102005063375A1 (de) * 2005-09-15 2007-04-19 Schülke & Mayr GmbH Antimikrobielle Zubereitungen mit einem Gehalt an Octenidindihydrochlorid verkapselt in Liposomen
DE102005048131A1 (de) * 2005-10-06 2007-04-12 Bayer Innovation Gmbh Antimikrobielle Kunststoffzusammensetzung mit niedriger Elutionsrate und langer Wirksamkeit
DE102005048132A1 (de) * 2005-10-06 2007-04-12 Bayer Innovation Gmbh Verfahren zur Herstellung antimikrobieller Kunststoffzusammensetzungen
DE102006012991A1 (de) 2006-03-22 2007-10-11 Bayer Innovation Gmbh Verfahren und Vorrichtung zum optischen Auslesen von Informationen
DE102006051891A1 (de) * 2006-10-31 2008-05-08 Schülke & Mayr GmbH Antimikrobiell wirksame Zusammensetzung mit einem Gehalt an Bispyridiniumalkan
DE102008011691A1 (de) 2008-02-28 2009-09-10 Schülke & Mayr GmbH Stabilisierte, antimikrobiell wirksame Zusammensetzung mit einem Gehalt an Bispyridiniumalkan
DE102009049504A1 (de) 2009-10-15 2011-04-21 Schülke & Mayr GmbH Wund- und Schleimhautantiseptikum auf der Basis von Bispyridiniumalkanen
DE102010022367A1 (de) 2010-04-20 2011-10-20 Klosterfrau Berlin Gmbh Gel, insbesondere Gleitgel, und seine Verwendung
EP2384733B1 (de) * 2010-05-07 2016-07-27 Ivoclar Vivadent AG Antimikrobielle Dentalwerkstoffe
DE102010025932A1 (de) 2010-07-02 2012-01-05 Schülke & Mayr GmbH Antiseptikum auf der Basis von Bispyridiniumalkanen
DE102011077432A1 (de) * 2011-06-10 2012-12-13 Schülke & Mayr GmbH Verwendung von Bispyridiniumalkanen zur Abtötung von Sporen
DE102012215511A1 (de) 2012-08-31 2014-06-12 Schülke & Mayr GmbH Verfahren zur Herstellung einer Bispyridiniumalkan enthaltenden halbfesten Zubereitung
DE102013223657A1 (de) 2013-11-20 2015-05-21 Schülke & Mayr GmbH Kit für die Erzeugung von Bispyridiniumalkan enthaltenden Schäumen
DE102014107412A1 (de) 2014-05-26 2015-12-17 Schülke & Mayr GmbH Gefärbte desinfizierende Zubereitung auf Basis von Bispyridiniumalkan
DE102014107413A1 (de) 2014-05-26 2015-11-26 Schülke & Mayr GmbH Kit für das Einfärben von desinfizierten Bereichen einer Oberfläche
DE102014115080A1 (de) 2014-10-16 2016-04-21 Schülke & Mayr GmbH Verwendung von Fettsäureester zur Verbesserung der antimikrobiellen Wirksamkeit eines alkoholischen Desinfektionsmittels
KR20200044872A (ko) * 2017-08-21 2020-04-29 디쉬맨 카보젠 아믹스 리미티드 옥테니딘 기반의 화합물들
EP3771770A1 (en) 2019-07-29 2021-02-03 The Procter & Gamble Company Antimicrobial freshening compositions
EP3771337A1 (en) 2019-07-29 2021-02-03 The Procter & Gamble Company Antimicrobial composition
EP3771338A1 (en) 2019-07-29 2021-02-03 The Procter & Gamble Company Acidic antimicrobial composition
EP3771339A1 (en) * 2019-07-29 2021-02-03 The Procter & Gamble Company Disinfectant composition
EP3771741A1 (en) 2019-07-29 2021-02-03 The Procter & Gamble Company Fabric treatment
EP3816272B1 (en) 2019-10-31 2023-11-01 The Procter & Gamble Company Fabric care composition
CN114989076A (zh) * 2022-06-07 2022-09-02 八叶草健康产业研究院(厦门)有限公司 一种奥替尼啶碱的制备方法

Also Published As

Publication number Publication date
JPS6033108B2 (ja) 1985-08-01
NO770631L (no) 1977-08-26
DK81277A (da) 1977-08-26
BE851807A (fr) 1977-08-25
NL7701965A (nl) 1977-08-29
PH22315A (en) 1988-07-29
JPS52105228A (en) 1977-09-03
FI770593A (no) 1977-08-26
NO823274L (no) 1977-08-26
AR214876A1 (es) 1979-08-15
CH620907A5 (en) 1980-12-31
NL186086B (nl) 1990-04-17
CA1073911A (en) 1980-03-18
AU510149B2 (en) 1980-06-12
FI66850B (fi) 1984-08-31
DE2708331C2 (no) 1991-03-21
FR2342286A1 (fr) 1977-09-23
FI66850C (fi) 1984-12-10
SE7702072L (sv) 1977-10-10
NO148779B (no) 1983-09-05
NO150758B (no) 1984-09-03
AT355571B (de) 1980-03-10
FR2342286B1 (no) 1979-03-09
IE45336B1 (en) 1982-08-11
AU2258277A (en) 1978-08-31
PT66224A (en) 1977-03-01
SE432421B (sv) 1984-04-02
NL186086C (nl) 1990-09-17
PT66224B (en) 1978-07-14
MX5132E (es) 1983-03-28
IE45336L (en) 1977-08-25
AR218052A1 (es) 1980-05-15
GB1533952A (en) 1978-11-29
IL51520A0 (en) 1977-04-29
DE2708331A1 (de) 1977-09-08
NO148779C (no) 1983-12-14
PH25097A (en) 1991-02-19
ATA129777A (de) 1979-08-15
DK147638B (da) 1984-10-29
IL51520A (en) 1980-12-31
DK147638C (da) 1985-07-15
ES456252A1 (es) 1978-02-01
HK67484A (en) 1984-09-07
LU76837A1 (no) 1977-09-12

Similar Documents

Publication Publication Date Title
NO150758C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme bis-pyridiniumalkan- og -xylenforbindelser
NO147025C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme pyridinyl-2(1h)-pyridinoner
NO770804L (no) Analogifremgangsm}te for fremstilling av terapeutisk aktive aminoalyl-heterocykliske forbindelser
SE431088B (sv) Forfarande for framstellning av terapeutiskt verksamma benshydrylsulfinylderivat
SE441827B (sv) Forfarande for framstellning av fenoxiaminopropanoler
NO154522C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme kinolinderivater.
NO151040C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-halogenpyrimid-2-oner
NO147953C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive antracyklinglukosider
NO144848C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme 4-hydroksyfenylalkanolamin-derivater
NO151201C (no) Fremgangsmaate for fremstilling av terapeutisk virksomme antigenderivater
NO143796C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme piperazinyliminorifamyciner
NO152255C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme imidazolylvinylethere
NO150081C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme derivater av perhydro-aza-heterocykler
NO145762C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive antracyklinglykosidiske forbindelser
SE441354B (sv) Forfarande for framstellning av meta-fenoxibensaldehyd
NO143992C (no) Fremgangsmaate for fremstilling av heksanitrostilben
NO146022C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme benzofenonderivater
NO146356C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive alkanolaminderivater
NO151285C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive di-o-n-alkyl-glycerolderivater
NO148673C (no) Analogifremgangsmaate ved fremstilling av farmakologisk virksomme tiofenderivater
NO148454C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidin-dionderivater
NO151196C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme fluorerte alkenylendiaminderivater
NO771884L (no) Fremgangsm}te for fremstilling av terapeutisk aktive polyribonukleotider
NO774067L (no) Fremgangsmaate for fremstilling av cellulosemasse
NO151008C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive nitroforbindelser